Michael Weigand

915 total citations
8 papers, 238 citations indexed

About

Michael Weigand is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Michael Weigand has authored 8 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Michael Weigand's work include SARS-CoV-2 and COVID-19 Research (3 papers), Sepsis Diagnosis and Treatment (2 papers) and COVID-19 Clinical Research Studies (2 papers). Michael Weigand is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Sepsis Diagnosis and Treatment (2 papers) and COVID-19 Clinical Research Studies (2 papers). Michael Weigand collaborates with scholars based in Germany, Switzerland and Denmark. Michael Weigand's co-authors include Martin Röcken, Ralph Mocikat, Christoph Brenner, David J. Roser, Daniel Teupser, Lesca M. Holdt, Mathias Bruegel, Peter Eichhorn, Matthias Mann and Maximilian T. Strauss and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Michael Weigand

8 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Weigand Germany	5	64	64	54	53	44	8	238
Diana J. Garay‐Baquero United Kingdom	10	71 1.1×	69 1.1×	19 0.4×	123 2.3×	80 1.8×	14	272
Patrick Wijten Qatar	7	54 0.8×	98 1.5×	20 0.4×	22 0.4×	29 0.7×	9	277
Dahee Shim South Korea	8	100 1.6×	85 1.3×	31 0.6×	70 1.3×	61 1.4×	14	279
Jinsong Mu China	11	62 1.0×	24 0.4×	25 0.5×	136 2.6×	110 2.5×	20	307
Sara Terreri Italy	12	160 2.5×	122 1.9×	109 2.0×	107 2.0×	44 1.0×	23	380
Manuel Ceballos Guerrero Spain	6	174 2.7×	16 0.3×	69 1.3×	30 0.6×	86 2.0×	14	373
Peijun Zhou China	13	178 2.8×	33 0.5×	96 1.8×	42 0.8×	69 1.6×	39	390
Zhiguo Li China	10	158 2.5×	45 0.7×	31 0.6×	11 0.2×	35 0.8×	26	284
Daxian Wu China	10	87 1.4×	25 0.4×	39 0.7×	25 0.5×	179 4.1×	25	325
Rasha Ahmed Egypt	12	97 1.5×	35 0.5×	68 1.3×	11 0.2×	78 1.8×	36	366

Countries citing papers authored by Michael Weigand

Since Specialization

Citations

This map shows the geographic impact of Michael Weigand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Weigand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Weigand more than expected).

Fields of papers citing papers by Michael Weigand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Weigand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Weigand. The network helps show where Michael Weigand may publish in the future.

Co-authorship network of co-authors of Michael Weigand

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Weigand. A scholar is included among the top collaborators of Michael Weigand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Weigand. Michael Weigand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Winklmeier, Stephan, Heike Rübsamen, Paul R. Wratil, et al.. (2024). Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva. Frontiers in Immunology. 15. 1330864–1330864. 4 indexed citations

Scharf, Christina, Ines Schroeder, Michael Paal, et al.. (2022). Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study. Annals of Intensive Care. 12(1). 44–44. 22 indexed citations

Nagel, Dorothea, et al.. (2022). Performance testing of four automated coagulation analyzers in a university hospital setting with focus on global coagulation assays. International Journal of Laboratory Hematology. 44(3). 643–653. 2 indexed citations

Buchholtz, Marie‐Luise, Peter Eichhorn, Michael Weigand, et al.. (2021). SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS. PLoS ONE. 16(5). e0251587–e0251587. 3 indexed citations

Geyer, Philipp E., Sophia Doll, Sebastian Virreira Winter, et al.. (2021). High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion. EMBO Molecular Medicine. 13(8). e14167–e14167. 88 indexed citations

Roser, David J., et al.. (2017). Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN‐γ and induces NK cell‐dependent lymphoma control without other immunotherapies. International Journal of Cancer. 140(9). 2125–2133. 95 indexed citations

Klein, Matthias, Denis Grandgirard, Matthias Wittwer, et al.. (2010). Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis. BMC Infectious Diseases. 10(1). 84–84. 17 indexed citations

Vogeser, Michael, Michael Weigand, Peter Fraunberger, Heike Fischer, & Peter Cremer. (2000). Evaluation of the ADVIA® Centaur™ TSH-3 Assay. Clinical Chemistry and Laboratory Medicine (CCLM). 38(4). 331–334. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact